EVEXIA
NSE: EVEXIA

Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Key Statistics

Investment Rating

  • Master Rating:
  • Evexia Lifecare has an operating revenue of Rs. 72.27 Cr. on a trailing 12-month basis. An annual revenue de-growth of -58% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 53 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Synopsis

BSE-Chemicals-Specialty

Evexia Lifecare belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 71.63 Cr. and Equity Capital is Rs. 61.93 Cr. for the Year ended 31/03/2022. Evexia Lifecare Ltd. is a Public Limited Listed company incorporated on 23/11/1990 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L23100GJ1990PLC014692 and registration number is 014692.
  • Market Cap
  • 115
  • Sales
  • 68
  • Shares in Float
  • 52.64
  • No of funds
  • 4
  • Yield
  • Book Value
  • 1.42
  • U/D Vol ratio
  • 0.7
  • LTDebt / Equity
  • Alpha
  • -0.35
  • Beta
  • 0.61

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 15.12%
  • 43.02%
  • 43.02%
  • Mutual Funds
  • 0.08%
  • 0.08%
  • 0.08%
  • Foreign Portfolio Investors
  • 1.47%
  • 3.64%
  • Financial Institutions/ Banks
  • 0.23%
  • 0.23%
  • 0.23%
  • Individual Investors
  • 81.5%
  • 50.08%
  • 32.47%
  • Others
  • 3.07%
  • 5.12%
  • 20.56%

Management

  • Name
  • Designation
  • Mr. Jayesh R Thakkar
  • Chairman & Managing Director
  • Mr. Salil S Patel
  • Independent Director
  • Mr. Kartik B Mistry
  • Independent Director
  • Mr. Naresh A Patel
  • Independent Director
  • Mr. Hasmukh D Thakkar
  • Non Independent Director
  • Mr. Chandresh V Kahar
  • Independent Director
  • Ms. Payal Gajjar
  • Independent Woman Director

Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

FAQs

What is Share Price of ?

share price is ₹ As on 13 August, 2022 | 07:57

Q1FY23